"Within the next five years, our objective is to leverage the production capacities of our two plants to grow our sales from USD12 million today of…
In Conversation
In the end, no matter what political commentators or economists say, the UK will remain a top six or five economy globally, and in any scenario,…
"Currently, we are focusing on finalizing our latest infrastructural expansion which will enable the Quality control analysis and QP release of 2000 batches per month, mainly…
"Our competitors are at least five years behind, so we enjoy a great first-mover advantage. This gives us an extremely strong positioning in that market and…
"In the grand scheme of things, our strategy is to gain a dominant position in a few, well-identified product categories rather than building a huge product…
"In addition to the large amount of outstanding Chinese professors and scientists who have studied abroad returning to China, Shenzhen has also been successful in attracting…
"Creation is based on the value we can bring to solve real market needs. Otherwise, ‘innovation’ is empty. My job as CEO is to know the…
"Our current efforts to develop a HIV vaccine is being funded in the framework of the EU response to the 2030 agenda of the Sustainable Development…
“I really believe Malta is ideal for research and it can bring more knowledge and experience to our scientists and healthcare professionals."
" To sustain medical progress, the biopharmaceutical industry, that takes financial risks and invests a tremendous amount of time, resources, and capital to bring life-saving treatments…
"We continue to work very closely with pharma partners to deliver benefits to patients. Together we focus not only on new drugs but on lifestyle changes…
"Indian regulators have become important strategic partners for the FDA. Today, we regularly engage with them on everything from sharing information on FDA guidance and regulations…
